Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (1051-1060 of 1,212) with videos related to

Pageof 122
Sort By:
Frontiers in Neuroscience|June 14, 2021
High Fructose Corn Syrup-Moderate Fat Diet Potentiates Anxio-Depressive Behavior and Alters Ventral Striatal Neuronal SignalingAyanabha Chakraborti, Christopher Graham, Sophie Chehade, et al.
American Heart Journal|May 16, 2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialRaffaele De Caterina, Ulrika Andersson, John H Alexander, et al.
Journal of the American College of Cardiology|August 14, 2015
Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 TrialConnie N Hess, Stefan James, Renato D Lopes, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2020
Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidenceAnnetine C Gelijns, Alan J Moskowitz, Patrick T O'Gara, et al.
Circulation|December 28, 2018
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINADarren K McGuire, John H Alexander, Odd Erik Johansen, et al.
The American Journal of Cardiology|June 14, 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromesKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
HIV Medicine|December 31, 2025
Supporting long-term engagement in HIV clinical care: Learning from the COVID-19 pandemicR Dhairyawan, Sara Paparini, M Smuk, et al.
Toxicology and Applied Pharmacology|July 13, 2013
Distinct mechanisms of relaxation to bioactive components from chamomile species in porcine isolated blood vesselsR E Roberts, S Allen, A P Y Chang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 20, 2004
Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing lossThankam S Nair, Kelley E Kozma, Nickoleta L Hoefling, et al.
American Heart Journal|December 22, 2005
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trialsJohn M Galla, Kenneth W Mahaffey, Shelly K Sapp, et al.
Pageof 122

Showing results (1051-1060 of 1,212) with videos related to

Sort By:
Pageof 122
Frontiers in Neuroscience|June 14, 2021
High Fructose Corn Syrup-Moderate Fat Diet Potentiates Anxio-Depressive Behavior and Alters Ventral Striatal Neuronal SignalingAyanabha Chakraborti, Christopher Graham, Sophie Chehade, et al.
American Heart Journal|May 16, 2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialRaffaele De Caterina, Ulrika Andersson, John H Alexander, et al.
Journal of the American College of Cardiology|August 14, 2015
Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 TrialConnie N Hess, Stefan James, Renato D Lopes, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2020
Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidenceAnnetine C Gelijns, Alan J Moskowitz, Patrick T O'Gara, et al.
Circulation|December 28, 2018
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINADarren K McGuire, John H Alexander, Odd Erik Johansen, et al.
The American Journal of Cardiology|June 14, 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromesKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
HIV Medicine|December 31, 2025
Supporting long-term engagement in HIV clinical care: Learning from the COVID-19 pandemicR Dhairyawan, Sara Paparini, M Smuk, et al.
Toxicology and Applied Pharmacology|July 13, 2013
Distinct mechanisms of relaxation to bioactive components from chamomile species in porcine isolated blood vesselsR E Roberts, S Allen, A P Y Chang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 20, 2004
Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing lossThankam S Nair, Kelley E Kozma, Nickoleta L Hoefling, et al.
American Heart Journal|December 22, 2005
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trialsJohn M Galla, Kenneth W Mahaffey, Shelly K Sapp, et al.
Pageof 122